260 related articles for article (PubMed ID: 6667763)
21. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
[TBL] [Abstract][Full Text] [Related]
22. The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects.
Brosche T; Platt D; Dorner H
Br J Clin Pract Suppl; 1990 Aug; 69():12-9. PubMed ID: 2083168
[TBL] [Abstract][Full Text] [Related]
23. [Lipid metabolism and atherogenesis in tuberculosis in experimental animals].
Kamyshnikov VS; Kolb VG
Probl Tuberk; 1993; (4):53-5. PubMed ID: 8127844
[TBL] [Abstract][Full Text] [Related]
24. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
Uyuklu M; Meiselman HJ; Baskurt OK
Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
[TBL] [Abstract][Full Text] [Related]
25. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
26. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
27. Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic children.
Ferretti G; Simonetti O; Offidani AM; Messini L; Cinti B; Marshiseppe I; Bossi G; Curatola G
Pediatr Res; 1993 May; 33(5):506-9. PubMed ID: 8511025
[TBL] [Abstract][Full Text] [Related]
28. Plasma and red cell lipids in sickle cell disease.
Akinyanju PA; Akinyanju CO
Ann Clin Lab Sci; 1976; 6(6):521-4. PubMed ID: 999221
[TBL] [Abstract][Full Text] [Related]
29. Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients.
Miossec P; Zkhiri F; Pariès J; David-Dufilho M; Devynck MA; Valensi PE
Diabet Med; 1999 May; 16(5):424-30. PubMed ID: 10342343
[TBL] [Abstract][Full Text] [Related]
30. Nonenzymatic glycosylation of proteins. II. Does glycosylation of low density lipoproteins affect lipid composition of erythrocyte membranes?
Watała C; Kordacka M
Ann Clin Res; 1987; 19(3):194-7. PubMed ID: 3674735
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte lipid alterations in pediatric cholestatic liver disease: relationship to serum bile acids.
Cynamon HA; Isenberg JN
Hepatogastroenterology; 1986 Jun; 33(3):98-100. PubMed ID: 3744283
[TBL] [Abstract][Full Text] [Related]
32. Differential blood lipid pattern in diabetics and atherosclerotics.
Eisa EA; Ismail AA; Fayek KI; Sherada HM
J Egypt Med Assoc; 1972; 55(7):471-7. PubMed ID: 4348557
[No Abstract] [Full Text] [Related]
33. Cholesterol:phospholipid ratio is elevated in platelet plasma membrane in patients with hypertension.
Benjamin N; Robinson BF; Graham JG; Wilson RB
J Hum Hypertens; 1990 Jun; 4(3):273-6. PubMed ID: 2362260
[TBL] [Abstract][Full Text] [Related]
34. [Cholesterol-acceptor properties of high-density lipoproteins with respect to erythrocyte membranes in patients with ischemic heart disease].
Torkhovskaia TI; Gorbatenkova EA; Dudaev VA; Chesnokova IaM; Azizova OA
Vopr Med Khim; 1986; 32(2):101-5. PubMed ID: 3010565
[TBL] [Abstract][Full Text] [Related]
35. Alteration of plasma and erythrocyte membrane lipid components in hyperthyroid rats.
Ruggiero FM; Landriscina C; Gnoni GV; Quagliariello E
Horm Metab Res; 1984 Jan; 16(1):37-40. PubMed ID: 6698491
[TBL] [Abstract][Full Text] [Related]
36. Altered insulin receptor processing and membrane lipid composition in erythrocytes of cirrhotic patients.
Peterson SW; Angelico M; Masella R; Foster K; Gandin C; Cantafora A
Ital J Gastroenterol; 1992 Feb; 24(2):65-71. PubMed ID: 1576365
[TBL] [Abstract][Full Text] [Related]
37. Red blood cell lipid alterations in type II diabetes mellitus.
Prisco D; Paniccia R; Coppo M; Vanni D; Rogasi PG; Tramontana M; Abbate R; Gensini GF
Thromb Res; 1989 Jun; 54(6):751-8. PubMed ID: 2781513
[TBL] [Abstract][Full Text] [Related]
38. [Dynamic changes in the indices of lipid metabolism in erythrocyte membranes at different times of the development of alloxan diabetes].
Gevorkian DM
Biull Eksp Biol Med; 1989 Mar; 107(3):298-300. PubMed ID: 2713467
[TBL] [Abstract][Full Text] [Related]
39. Effect of body lipid mass on red blood cell-and plasma-tocopherol levels.
Nishida Y; Iwakoshi M; Nakagawa S; Mino M
J Nutr Sci Vitaminol (Tokyo); 1982; 28(3):237-46. PubMed ID: 7131100
[TBL] [Abstract][Full Text] [Related]
40. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
Watala C; Winocour PD
Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
